Isolated Testicular Metastasis of Prostate Cancer after Radical Prostatectomy: Case Report and Literature Review

2015 ◽  
Vol 95 (4) ◽  
pp. 483-485 ◽  
Author(s):  
Artur Gibas ◽  
Marcin Sieczkowski ◽  
Wojciech Biernat ◽  
Marcin Matuszewski

Clinical recurrence of prostate cancer manifested as a testicular mass is an extremely rare condition. We report a case of a 58-year-old patient with a testicular tumor who underwent orchiectomy 7 years after radical prostatectomy. The pathology analysis confirmed metastasis from prostate carcinoma. After one year, the patient had no signs of biochemical and clinical recurrence. This argues for considering metastasectomy in such patients.

2021 ◽  
pp. 039156032110091
Author(s):  
Salvatore Smelzo ◽  
Guglielmo Mantica ◽  
Roberta Lucianò ◽  
Nazario Pio Tenace ◽  
Davide De Marchi ◽  
...  

Introduction: We aim to present a rare case of a patient who developed a late testicular metastasis of PCa after radical prostatectomy. Case description: A 78 years old man presenting for left testicular swelling slowly increasing of size over the last 2 months. He underwent a retropubic radical prostatectomy and extended bilateral lymphadenectomy in 2007 for prostatic adenocarcinoma. At the time of the presentation the last PSA was 0.91 ng/mL. The patient underwent a standard left orchifunicolectomy in April 2019 without intra- or perioperative complications. The pathological analysis showed a testicular metastasis of acinar adenocarcinoma. Conclusions: In conclusion, testicular metastasis from PCa are uncommon conditions. PSA evaluation and physical examination of all sites of metastasis and accurate evaluation of all signs/symptoms during the clinical visit remains crucial to the diagnosis of recurrence.


2004 ◽  
Vol 171 (4S) ◽  
pp. 224-225
Author(s):  
Gregory S. Jack ◽  
Tracey L. Krupski ◽  
George V. Thomas ◽  
Jackielyn Abellada ◽  
Jean B. De Kernion ◽  
...  

2021 ◽  
Vol 49 (2) ◽  
pp. 030006052199223
Author(s):  
Xiaolin Zhang ◽  
Hongmei Jiao ◽  
Xinmin Liu

Esophageal diverticulum with secondary bronchoesophageal fistula is a rare clinical entity that manifests as respiratory infections, coughing during eating or drinking, hemoptysis, and sometimes fatal complications. In the present study, we describe a case of bronchoesophageal fistula emanating from esophageal diverticulum in a 45-year-old man who presented with bronchiectasis. We summarize the characteristics of this rare condition based on a review of the relevant literature.


2014 ◽  
Vol 8 (5-6) ◽  
pp. 458 ◽  
Author(s):  
Jae Heon Kim ◽  
Byung Wook Yoo ◽  
Won Jae Yang

Cyproterone acetate (CPA) is an anti-androgenic drug that has been used to manage prostate cancer. The drug is well-tolerated, but has hepatotoxic effects. Hepatic failure induced by CPA is rare and urologists tend to overlook its severity. We report a patient with metastatic prostate cancer who developed CPA-induced hepatic failure that manifested as bilirubinuria, which was initially misinterpreted as gross hematuria. The patient died despite receiving critical care. The aim of this study is to sound the alarm about CPA-induced hepatic failure.


BJPsych Open ◽  
2021 ◽  
Vol 7 (S1) ◽  
pp. S115-S115
Author(s):  
Ciara Clarke ◽  
Clodagh Rushe ◽  
Fintan Byrne

ObjectiveWe report a case of a 58-year-old gentleman who was hospitalised intermittently for one year due to treatment resistant schizophrenia. Prior to hospitalisation he had been prescribed standard antipsychotics for decades without full resolution of positive psychotic symptoms. During his final admission lasting six months he was guarded, suspicious, irritable, constantly paced the corridor and displayed thought block and paranoid persecutory delusions. He would not enter the assessment room or allow any blood or ECG monitoring, however, he was compliant with oral medication. He was successfully treated with high dose olanzapine (40mg/day) and was discharged to the community. The aim of this study is to bring awareness and add to the body of evidence for the use of high-dose olanzapine in patients with treatment resistant schizophrenia in whom a trial of clozapine is not possible.Case reportThe patient gave written consent for this case report to be written and presented. An extensive literature review was performed and key papers were identified. Discussion focuses on the key areas in the literature.DiscussionThis case demonstrates that high-dose olanzapine can be used effectively as an alternative to clozapine in treatment resistant schizophrenia.ConclusionThis case highlights the need for further evaluation of high-dose olanzapine as an alternative to clozapine in patients with treatment-resistant schizophrenia.


2018 ◽  
Vol 4 (1) ◽  
pp. 144-146 ◽  
Author(s):  
Gotardo Zini Pinho ◽  
Gustavo Ruschi Bechara ◽  
Samira Pereira das Posses ◽  
Carla Regina Santos De Carli ◽  
Marcio Maia Lamy de Miranda

2018 ◽  
Vol 4 (1) ◽  
Author(s):  
Tinnakorn Pluemvitayaporn ◽  
Sombat Kunakornsawat ◽  
Chaiwat Piyaskulkaew ◽  
Pritsanai Pruttikul ◽  
Warongporn Pongpinyopap

2020 ◽  
Vol 33 ◽  
pp. 101414
Author(s):  
Michael-Abdo-Jefferson Billy El khoury ◽  
Marie Van Eycken ◽  
Thierry Roumeguère ◽  
Simone Albisinni

Sign in / Sign up

Export Citation Format

Share Document